Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C4 | P17516 | 1/20 | 0.54 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.54 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | SLCO2A1 | Q92959 | 1/20 | 0.32 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.32 |
| ▸ | PTGER2 | P43116 | 4/20 | 0.31 |
| ▸ | SLC6A12 | P48065 | 3/20 | 0.31 |
| ▸ | SLC6A11 | P48066 | 3/20 | 0.31 |
| ▸ | SLC6A13 | Q9NSD5 | 3/20 | 0.31 |
| ▸ | PTGER4 | P35408 | 3/20 | 0.31 |
| ▸ | PTGER3 | P43115 | 2/20 | 0.31 |
| ▸ | PTGIR | P43119 | 2/20 | 0.30 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20303552 | 1.00 | AKR1C4 (0.54) | AKR1C4AKR1C3AKR1C2HTTALOX5 | |
| SCHEMBL5598064 | 1.00 | AKR1C4 (0.54) | AKR1C4AKR1C3AKR1C2HTTALOX5 | |
| SCHEMBL5383512 | 1.00 | AKR1C4 (0.54) | AKR1C4AKR1C3AKR1C2HTTALOX5 | |
| SCHEMBL30307635 | 0.90 | AKR1C4 (0.44) | AKR1C4AKR1C3AKR1C2HTTALOX5 | |
| SCHEMBL11840607 | 0.88 | AKR1C4 (0.40) | AKR1C4AKR1C3AKR1C2HTTTP53 | |
| SCHEMBL4399644 | 0.84 | AKR1C4 (0.38) | AKR1C4AKR1C3AKR1C2HTTALOX5 | |
| SCHEMBL28790649 | 0.84 | AKR1C4 (0.38) | AKR1C4AKR1C3AKR1C2HTTALOX5 | |
| SCHEMBL4399647 | 0.84 | AKR1C4 (0.38) | AKR1C4AKR1C3AKR1C2HTTALOX5 | |
| SCHEMBL4399643 | 0.84 | AKR1C4 (0.38) | AKR1C4AKR1C3AKR1C2HTTALOX5 | |
| SCHEMBL25276408 | 0.83 | HTT (0.46) | AKR1C4AKR1C3AKR1C2HTTALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-5171180-A | — | — | None | — | — | JP | disclosed |
| EP-4658077-A2 | PAENIBACILLUS ISOLATES AND USES THEREOF | Novonesis Plant Biosolutions A/S (DK) | 2025-12-10 | — | — | EP | disclosed |
| EP-4618745-A1 | USE OF ISOTIANIL FOR CONTROLLING PLASMODIOPHORA BRASSICA | Bayer Aktiengesellschaft (DE) | 2025-09-24 | — | — | EP | disclosed |
| US-20250241307-A1 | AQUEOUS COMPOSITIONS COMPRISING SOLUBILZED LIPO-CHITOOLIGOSACCHARIDES | Novonesis Plant Biosolutions A/S (DK) | 2025-07-31 | — | — | US | disclosed |
| WO-2024216218-A1 | AUTOMATED CLEANING SYSTEMS FOR SEED TREATERS AND RELATED METHODS | MONSANTO TECHNOLOGY LLC (US) | 2024-10-17 | — | — | WO | disclosed |
| US-20240342769-A1 | Automated Cleaning Systems For Seed Treaters And Related Methods | GUSTAFSON ENGINEERED SOLUTIONS LLC | 2024-10-17 | — | — | US | disclosed |
| WO-2024163534-A2 | PAENIBACILLUS ISOLATES AND USES THEREOF | NOVOZYMES BIOAG A/S (DK) | 2024-08-08 | — | — | WO | disclosed |
| EP-4384016-A1 | ACTIVE COMPOUND COMBINATIONS AND FUNGICIDE COMPOSITIONS COMPRISING THOSE | Bayer Aktiengesellschaft (DE) | 2024-06-19 | — | — | EP | disclosed |
| WO-2024104643-A1 | USE OF ISOTIANIL FOR CONTROLLING PLASMODIOPHORA BRASSICA | BAYER AKTIENGESELLSCHAFT (DE) | 2024-05-23 | — | — | WO | disclosed |
| WO-2024068517-A1 | 3-(HETERO)ARYL-5-CHLORODIFLUOROMETHYL-1,2,4-OXADIAZOLE AS FUNGICIDE | BAYER AKTIENGESELLSCHAFT (DE) | 2024-04-04 | — | — | WO | disclosed |
| EP-3855917-A1 | PESTICIDAL COMBINATIONS OF YERSINIA AND INSECT VIRUSES | Novozymes BioAG A/S (DK) | 2021-08-04 | — | — | EP | disclosed |
| WO-2021101937-A1 | PSEUDOMONAS ISOLATES AND USES THEREOF | NOVOZYMES BIOAG A/S (DK) | 2021-05-27 | — | — | WO | disclosed |
| WO-2021086695-A1 | MICROBACTERIUM ISOLATES AND USES THEREOF | NOVOZYMES BIOAG A/S (DK) | 2021-05-06 | — | — | WO | disclosed |
| WO-2021030400-A1 | PESTICIDAL COMBINATIONS OF YERSINIA AND PROTEASES | NOVOZYMES BIOAG A/S (DK) | 2021-02-18 | — | — | WO | disclosed |
| WO-2020068654-A1 | PESTICIDAL COMBINATIONS OF YERSINIA AND INSECT VIRUSES | NOVOZYMES BIOAG A/S (DK) | 2020-04-02 | — | — | WO | disclosed |
| WO-2019135972-A1 | BACILLUS ISOLATES AND USES THEREOF | MONSANTO TECHNOLOGY LLC (US) | 2019-07-11 | — | — | WO | disclosed |
| WO-2019104173-A1 | METHODS OF IMPROVING THE EFFECTIVENESS OF A CROP REFUGE | MONSANTO TECHNOLOGY LLC (US) | 2019-05-31 | — | — | WO | disclosed |
| US-7176163-B1 | Pharmacological effect potentiators for pesticides | MEIJA SEIKA KAISHA, LTD. (JP) | 2007-02-13 | — | — | US | disclosed |
| JP-H05171180-A | PERFUME COMPOSITION | KAO CORP | 1993-07-09 | — | — | JP | disclosed |
| US-3941828-A | Process for the preparation of cyclic ketones | FIRMENICH SA (CH) | 1976-03-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250241307-A1 | AQUEOUS COMPOSITIONS COMPRISING SOLUBILZED LIPO-CHITOOLIGOSACCHARIDES | DDOST, STT3B, LCT | AKR1C4 3306/4885AKR1C3 3179/4885AKR1C2 2923/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.